Please try another search
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Joyce Lea Frey-Vasconcells | - | - | Member of Scientific Advisory Board |
Karen K. Hirschi | - | 2010 | Member of Scientific Advisory Board |
Mahendra S. Rao | 60 | 2010 | Member of Scientific Advisory Board |
Dominick C. Colangelo | 57 | 2013 | CEO, President & Director |
Heidi M. Hagen | 52 | 2013 | Independent Director |
Alan L. Rubino | 66 | 2005 | Independent Director |
Steven C. Gilman | 68 | 2015 | Independent Director |
Kevin F. McLaughlin | 65 | 2015 | Independent Director |
Robert L. Zerbe | 70 | 2006 | Independent Chairman & Lead Director |
Paul Kevin Wotton | 61 | 2015 | Independent Director |
Lisa Wright | - | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review